BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 21439537)

  • 1. One-year results of transcatheter aortic valve implantation in severe symptomatic aortic valve stenosis.
    Gotzmann M; Bojara W; Lindstaedt M; Ewers A; Bösche L; Germing A; Lawo T; Bechtel M; Laczkovics A; Mügge A
    Am J Cardiol; 2011 Jun; 107(11):1687-92. PubMed ID: 21439537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic results and changes in myocardial function after transcatheter aortic valve implantation.
    Gotzmann M; Lindstaedt M; Bojara W; Mügge A; Germing A
    Am Heart J; 2010 May; 159(5):926-32. PubMed ID: 20435207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis.
    Ussia GP; Barbanti M; Petronio AS; Tarantini G; Ettori F; Colombo A; Violini R; Ramondo A; Santoro G; Klugmann S; Bedogni F; Maisano F; Marzocchi A; Poli A; De Carlo M; Napodano M; Fiorina C; De Marco F; Antoniucci D; de Cillis E; Capodanno D; Tamburino C;
    Eur Heart J; 2012 Apr; 33(8):969-76. PubMed ID: 22240494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise capacity in patients with severe symptomatic aortic stenosis before and six months after transcatheter aortic valve implantation.
    Bagur R; Rodés-Cabau J; Dumont E; Larochellière RD; Doyle D; Bertrand OF; Côté M; Poirier P; Pibarot P
    Am J Cardiol; 2011 Jul; 108(2):258-64. PubMed ID: 21545988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term quality of life improvement after transcatheter aortic valve implantation.
    Georgiadou P; Kontodima P; Sbarouni E; Karavolias GK; Smirli A; Xanthos T; Troupis T; Khouri M; Papadimitriou L; Voudris V
    Am Heart J; 2011 Aug; 162(2):232-7. PubMed ID: 21835282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality-of-life in elderly patients one year after transcatheter aortic valve implantation for severe aortic stenosis.
    Ussia GP; Barbanti M; Cammalleri V; Scarabelli M; Mulè M; Aruta P; Pistritto AM; Immè S; Capodanno D; Sarkar K; Gulino S; Tamburino C
    EuroIntervention; 2011 Sep; 7(5):573-9. PubMed ID: 21930461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart failure in severe aortic valve stenosis: prognostic impact of left ventricular ejection fraction and mean gradient on outcome after transcatheter aortic valve implantation.
    Gotzmann M; Rahlmann P; Hehnen T; Müller P; Lindstaedt M; Mügge A; Ewers A
    Eur J Heart Fail; 2012 Oct; 14(10):1155-62. PubMed ID: 22782969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcatheter aortic valve implantation in patients with severe symptomatic aortic valve stenosis-predictors of mortality and poor treatment response.
    Gotzmann M; Pljakic A; Bojara W; Lindstaedt M; Ewers A; Germing A; Mügge A
    Am Heart J; 2011 Aug; 162(2):238-245.e1. PubMed ID: 21835283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [POL-TAVI First--Polish report on transcatheter aortic valve implantation (TAVI) of Edwards-Sapien prosthesis in the first 19 high risk patients with severe aortic stenosis and comorbidities].
    Zembala M; Wilczek K; Przybylski R; Chodór P; Nadziakiewicz P; Krasoń M; Sadowski J; Dudek D; Kapelak B; Forysz D; Witkowski A; Demkow M; Chmielak Z; Kuśmierski K; Juraszyński Z; Bochenek A; Cisowski M; Trusz-Gluza M; Buszman P; Woś S; Kalarus Z; Poloński L; Gasior M; Opolski G; Ruzyłło W
    Kardiol Pol; 2009 Aug; 67(8):936-40. PubMed ID: 19784896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conduction disturbances and permanent cardiac pacing after transcatheter implantation of the CoreValve aortic bioprosthesis: initial single centre experience.
    Czerwińska K; Hryniewiecki T; Oręziak A; Dąbrowski M; Michałowska I; Witkowski A; Demkow M; Stępińska J; Orłowska Baranowska E; Rużyłło W
    Kardiol Pol; 2012; 70(2):121-8. PubMed ID: 22427074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of B-type natriuretic peptide to predict outcome of patients treated by transcatheter aortic valve implantation.
    Kefer J; Beauloye C; Astarci P; Renkin J; Glineur D; Dekleermaeker A; Vanoverschelde JL
    Am J Cardiol; 2010 Dec; 106(12):1782-6. PubMed ID: 21055712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of percutaneous aortic valve implantation to improve quality of life in patients >80 years of age.
    Bekeredjian R; Krumsdorf U; Chorianopoulos E; Kallenbach K; Karck M; Katus HA; Rottbauer W
    Am J Cardiol; 2010 Dec; 106(12):1777-81. PubMed ID: 21055715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life among patients undergoing transcatheter aortic valve implantation.
    Krane M; Deutsch MA; Bleiziffer S; Schneider L; Ruge H; Mazzitelli D; Schreiber C; Brockmann G; Voss B; Bauernschmitt R; Lange R
    Am Heart J; 2010 Sep; 160(3):451-7. PubMed ID: 20826252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term effects of transcatheter aortic valve implantation on neurohormonal activation, quality of life and 6-minute walk test in severe and symptomatic aortic stenosis.
    Gotzmann M; Hehen T; Germing A; Lindstaedt M; Yazar A; Laczkovics A; Mumme A; Mügge A; Bojara W
    Heart; 2010 Jul; 96(14):1102-6. PubMed ID: 19884109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome of transcatheter aortic valve implantation in patients with low-flow, low gradient aortic stenosis.
    Gotzmann M; Lindstaedt M; Bojara W; Ewers A; Mügge A
    Catheter Cardiovasc Interv; 2012 Apr; 79(5):693-701. PubMed ID: 21805576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incremental value of valvuloarterial impedance in evaluating the results of transcatheter aortic valve implantation in symptomatic aortic stenosis.
    Giannini C; Petronio AS; De Carlo M; Guarracino F; Benedetti G; Delle Donne MG; Dini FL; Marzilli M; Di Bello V
    J Am Soc Echocardiogr; 2012 Apr; 25(4):444-53. PubMed ID: 22244001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry.
    Zahn R; Gerckens U; Grube E; Linke A; Sievert H; Eggebrecht H; Hambrecht R; Sack S; Hauptmann KE; Richardt G; Figulla HR; Senges J;
    Eur Heart J; 2011 Jan; 32(2):198-204. PubMed ID: 20864486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrocardiographic changes and clinical outcomes after transapical aortic valve implantation.
    Gutiérrez M; Rodés-Cabau J; Bagur R; Doyle D; DeLarochellière R; Bergeron S; Lemieux J; Villeneuve J; Côté M; Bertrand OF; Poirier P; Clavel MA; Pibarot P; Dumont E
    Am Heart J; 2009 Aug; 158(2):302-8. PubMed ID: 19619709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thirty-day outcome after transcatheter aortic valve implantation compared with surgical valve replacement in patients with high-risk aortic stenosis: a matched comparison.
    Stöhr R; Dohmen G; Herpertz R; Brehmer K; Aktug O; Koos R; Altiok E; Stegemann E; Autschbach R; Marx N; Hoffmann R
    Coron Artery Dis; 2011 Dec; 22(8):595-600. PubMed ID: 22009042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival and predictive factors of mortality after 30 days in patients treated with percutaneous implantation of the CoreValve aortic prosthesis.
    Muñoz-García AJ; Hernández-García JM; Jiménez-Navarro MF; Alonso-Briales JH; Domínguez-Franco AJ; Rodríguez-Bailón I; Molina-Mora MJ; Hernández-Rodríguez P; Such-Martínez M; de Teresa-Galván E
    Am Heart J; 2012 Feb; 163(2):288-94. PubMed ID: 22305849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.